Barriers Prevent Patient Access to Personalized Therapies Identified by Molecular Tumor Profiling of Gynecologic Malignancies

Author： Hillman R. Tyler   Ward Kristy   Saenz Cheryl   McHale Michael   Plaxe Steven  

Publisher： MDPI

E-ISSN： 2075-4426|5|2|165-173

ISSN： 2075-4426

Source： Journal of Personalized Medicine, Vol.5, Iss.2, 2015-05, pp. : 165-173

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Photodynamic Therapy in Gynecologic Malignancies: A Review of the Roswell Park Cancer Institute Experience

By Mayor Paul C.   Lele Shashikant  

Cancers, Vol. 8, Iss. 10, 2016-09 ,pp. : 88-88

MDPI

Access to resources Recommend Favorite

Molecular Therapies in Thyroid Cancer

By Huyck Timothy   Agulnik Mark  

Pharmaceuticals, Vol. 4, Iss. 1, 2010-12 ,pp. : 91-100

MDPI

Access to resources Recommend Favorite

Trends in Personalized Therapies in Oncology: The (Venture) Capitalist’s Perspective

By Fleck Roman   Bach Daniel  

Journal of Personalized Medicine, Vol. 2, Iss. 1, 2012-03 ,pp. : 15-34

MDPI

Access to resources Recommend Favorite

High Cumulative Doses of Pegylated Liposomal Doxorubicin Are Not Associated with Cardiac Toxicity in Patients with Gynecologic Malignancies

By  

Chemotherapy, Vol. 56, Iss. 2, 2010-04 ,pp. : 108-111

Karger

Access to resources Recommend Favorite

Open Access Integrated Therapeutic and Diagnostic Platforms for Personalized Cardiovascular Medicine

By Gladding Patrick A.   Cave Andrew   Zareian Mehran   Smith Kevin   Hussan Jagir   Hunter Peter   Erogbogbo Folarin   Aguilar Zoraida   Martin David S.   Chan Eugene   Homer Margie L.   Shevade Abhijit V.   Kassemi Mohammad   Thomas James D.   Schlegel Todd T.  

Journal of Personalized Medicine, Vol. 3, Iss. 3, 2013-08 ,pp. : 203-237

MDPI

Access to resources Recommend Favorite